Unusual recurrence in advanced ovarian cancer after interval cytoreductive surgery and HIPEC

被引：0
|
作者：
Sonkusare, Shipra [1 ,2 ]
Prasannakumar, Somashekhar Sampige [3 ]
Ahuja, Vijay [1 ]
Kumar, Rohit [3 ]
机构：
[1] Aster Hosp Inc, Gynaecol Oncol, Bangalore, Karnataka, India
[2] All India Inst Med Sci Nagpur, Obstet & Gynaecol, Nagpur, Maharashtra, India
[3] Aster Hosp Inc, Surg Oncol, Bangalore, Karnataka, India
来源：
BMJ CASE REPORTS | 2025年 / 18卷 / 01期
关键词：
Cancer - see Oncology; Obstetrics and gynaecology; Cancer; Oncology; CHEMOTHERAPY; BEVACIZUMAB; DOXORUBICIN; PACLITAXEL; SURVIVAL; TRIAL;
D O I：
10.1136/bcr-2024-262137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ovarian cancer is the second most fatal gynaecological malignancy. The relapses after treatment of ovarian cancer usually occur within 2 years after completion of the first-line therapy. Recurrent ovarian cancer commonly presents as peritoneal surface deposits in the abdomen with or without ascites. A delayed relapse presenting as a solitary lesion in the urinary bladder wall is unusual in patients treated for advanced ovarian cancer. We report the successful management of a case of solitary metastasis of ovarian cancer in the urinary bladder wall, which occurred more than 6 years after achieving a complete remission state.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study
    Manuel, Duran-Martinez
    Gonzalo, Gomez-Duenas
    Lidia, Rodriguez-Ortiz
    Manuel, Sanchez-Hidalgo Juan
    Antonio, Gordon-Suarez
    Angela, Casado-Adam
    Sebastian, Rufian-Pena
    Francisca, Valenzuela-Molina
    Blanca, Rufian-Andujar
    Carmen, Vazquez-Borrego Maria
    Antonio, Romero-Ruiz
    Javier, Briceno-Delgado
    Alvaro, Arjona-Sanchez
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, 38 (01): : 66 - 74
  • [32] Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study
    Manuel Durán-Martínez
    Gonzalo Gómez-Dueñas
    Lidia Rodriguez-Ortíz
    Juan Manuel Sanchez-Hidalgo
    Antonio Gordón-Suárez
    Ángela Casado-Adam
    Sebastián Rufián-Peña
    Francisca Valenzuela-Molina
    Blanca Rufián-Andujar
    María Carmen Vázquez-Borrego
    Antonio Romero-Ruiz
    Javier Briceño-Delgado
    Álvaro Arjona-Sánchez
    Surgical Endoscopy, 2024, 38 : 66 - 74
  • [33] Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer
    Bhatt, Aditi
    Sinukumar, Snita
    Kepenekian, Vahan
    Kammar, Praveen
    Mehta, Sanket
    Shaikh, Sakina
    Gertych, Witold
    Bakrin, Naoual
    Glehen, Olivier
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Cytoreductive surgery for advanced stages of ovarian cancer
    Dauplat, J
    Le Bouëdec, G
    Pomel, C
    Scherer, C
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 19 (01): : 42 - 48
  • [35] Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?
    Mysona, David Pierce
    Ghamande, Sharad
    She, Jin-Xiong
    Tran, Lynn
    Tran, Paul
    Rungruang, Bunja J.
    Chan, John K.
    Bae-Jump, Victoria
    Gehrig, Paola A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (07) : 3605 - 3615
  • [36] Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?
    David Pierce Mysona
    Sharad Ghamande
    Jin-Xiong She
    Lynn Tran
    Paul Tran
    Bunja J. Rungruang
    John K. Chan
    Victoria Bae-Jump
    Paola A. Gehrig
    Annals of Surgical Oncology, 2021, 28 : 3605 - 3615
  • [37] PREDICTION OF RESIDUAL DISEASE AFTER INTERVAL CYTOREDUCTIVE SURGERY FOR EPITHELIAL OVARIAN CANCER
    van de Vrie, R.
    Korse, T.
    Karslen, M.
    van Driel, W.
    Kenter, G.
    Lok, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1703 - 1703
  • [38] Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
    McNamara, Blair
    Guerra, Rosa
    Qin, Jennifer
    Craig, Amaranta D.
    Chen, Lee-May
    Varma, Madhulika G.
    Chapman, Jocelyn S.
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 38
  • [39] Splenectomy in cytoreductive surgery for advanced ovarian cancer
    Bilgin T.
    Özerkan K.
    Ozan H.
    Archives of Gynecology and Obstetrics, 2005, 271 (4) : 329 - 331
  • [40] Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective
    Lof, Pien
    van Soolingen, Neeltje J.
    Piek, Jurgen M. J.
    Aarts, Johanna W. M.
    Retel, Valesca P.
    Bukman, Maarten
    Smorenburg, Carolina H.
    van Driel, Willemien J.
    Amant, Frederic
    Trum, Johannes W.
    Lok, Christianne A. R.
    GYNECOLOGIC ONCOLOGY, 2024, 187 : 227 - 234
12345